-
Very excited about this commercialization project; integrating biomarker-based business model with
@Azure and@msPartner service delivery platform!#cfDNA#EV#datahttps://twitter.com/biodynsd/status/1223047381588930560 … -
New! Lo & colleagues delineate the process of cell-free DNA fragmentation http://bit.ly/2RGoxwf
#cfDNA -
Swift Accel NGS® 2S Library Kits Higher library complexity for ultra low-input DNA and damaged DNA samples The best prep for ChiP, Hi-C, FFPE, cell-free DNA, and low input metagenomes
#NGS#WGS#cfDNA#liquidbiopsy#metagenomics#HiC#FFPE#CHiPhttps://youtu.be/BHmRG_Gn_bw -
Making libraries from a bit challenging & low input samples like cfDNA or FFPE? Check the advantages of
@SwiftBioSci 2S chemistry#NGS#WGS#cfDNA#liquidbiopsy#metagenomics#FFPEhttps://www.youtube.com/watch?v=BHmRG_Gn_bw&feature=youtu.be … -
Congrats
@leal_md_sp for great study on#cfDNA diversity and impact on response monitoring#liquidbiopsies#filterOUTbiologicalnoise#CHIPpic.twitter.com/dFgFT8k3MI
-
Cutting-edge session on
#cfDNA today at 2:10 pm with Dr. Christopher Smith at the main stage!#Festivalofgenomics https://bit.ly/38R9aHI pic.twitter.com/KYwIe0EQKn
-
Identifying responders remains a key challenge in
#precisiononcology. Our paper in@NatureComms explores the impact of filtering out the signal from leukocytes in#cfDNA to better predict recurrence in#gastriccancer.@velculescu@hopkinskimmel@TheMarkFdn https://rdcu.be/b0SxF -
Must use caution (and still use tissue!) as the number of markers expand .... but NILE did show
% PPV for egfr, alk, ros1, and braf @CharuAggarwalMD@HemOncToday#cfDNA#liquidbiopsy#lcsmpic.twitter.com/6SipVyHftt
Prikaži ovu nit -
Platform specific detection of
#somatic#SNVs in#cfDNA from#NGS data using#ABEMUS with@FrancescaBZNY NicolaCasiraghi@f_orlando_@CIBIO_UniTrento@mishabeltran@EngIPM@GertattardIdalhttps://doi.org/10.1093/bioinformatics/btaa016 … -
Very interesting and well-written review on cfDNA in cancer and placenta https://www.mdpi.com/2073-4409/8/11/1459/htm …
#placenta#cancer#epigenomics#biomarkers#cfDNA#methylation -
This is 100% the craziest poster at
#ASH19 - if true (a big if!) this is some bizarre and fascinating biology.#cfDNA#transposon@WinshipAtEmorypic.twitter.com/oNH4dNo79x
-
#CollinsTweetorial re cell free (cf) and circulating tumour (ct) DNA. Lesson 1: not the same thing! - cfDNA - all DNA not in cells. Found in healthy controls, often from cell turnover during haematopoiesis - ctDNA - derived from tumour so should not be there in controls#cfDNA pic.twitter.com/PbQdfAHK4s
Prikaži ovu nit -
New work from Reis-Filho and
@PedramRazavi1 in @NatureMedicine reporting a comprehensive#cfDNA analysis revealing#clonalhematopoiesis as major source of somatic mutations in plasma. @sloan_kettering#breastcancer#lungcancerhttps://www.nature.com/articles/s41591-019-0652-7 … -
Our review of technological considerations, pre-analytical variables and reference materials for
#EVs,#cfDNA,#CTCs and#cfRNA in liquid biopsy testing is now published in Molecular Aspects of Medicine@ELSpharma@egeeuric: https://doi.org/10.1016/j.mamblob:https://twitter.com/e3f3794d-023c-4cf9-b605-2c14adfe14ec.2019.10.005 …pic.twitter.com/0sYBXWvFKf
-
Here come our
#liquidbiopsy assay!! Measure TMB, MSI, CNV and SNV in blood samples with TruSight Oncology 500 ctDNA. Runs on a#NovaSeq.#TSO500#oncology#ctDNA#cfDNA https://emea.illumina.com/company/news-center/feature-articles/TSO-500-NovaSeq.html?langsel=/gb/ … -
Fiesty panel debating the merits and pitfalls of
#liquidbiopsy to close#TAS19 last week.#cfDNA was predicted to beat#CTCs... just like#ENG was supposed to thrash#RSA... and the winner was...#exosomes!pic.twitter.com/OA1ehTqFiN
-
It was an honor to be selected by
@rdienstmann, a pioneer and thought leader in this field.#ESMO2019#ESMO19#cfDNA. Great collaboration with@NUFeinbergMed@lexentbiohttps://twitter.com/aztezcan/status/1178642420583583744 …
-
#Potential applications of#cell-free#DNA in#cancer management.#genetic#cfDNA#liquidbiopsy#likitbiyopsi#oncology
The emerging role of cell-free DNA as a molecular marker for cancer managementpic.twitter.com/0sA0OgOrAF
-
Ever wonder if there was a simple, yet reliable way to differentiate
#infection from#disease ? My brilliant brother@cfDNAlex used#cfDNA#methylation signatures to differentiate#BKV replication from#BKV disease after#KThttps://www.pnas.org/content/early/2019/08/23/1906320116 … -
Welcome new literature bots (based on PubMed, bioRxiv, medRxiv):

@cfDNA_papers – cell free DNA (#cfDNA);
@epicancerpapers – cancer epigenetics; This is in addition to the existing bots:@DNAbinding,@CTCF_Papers,@TF_binding_bot,@Nucleosome_Bot
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.